Literature DB >> 18265539

Thyroid dysfunction in patients with Down syndrome.

Ming-Hua Chen1, Shyh-Jye Chen, Li-Ying Su, Winnie Yang.   

Abstract

BACKGROUND: The close relationship between thyroid disorder and Down syndrome (DS) had been widely reported in the literature. The aim of this study was to assess the prevalence rate and the pattern of thyroid dysfunction in DS in Taiwan.
METHODS: A total of 50 Down syndrome (DS) patients from Yang-Ming Home for Disabled, were recruited. In all patients, serum T3, T4, free T4, TSH, thyroid peroxidase antibody (anti-TPO) and anti-TSH receptor antibody were measured. The control group consisted of 212 healthy adults who underwent routine health examination in this hospital.
RESULTS: Among 50 DS patients, 8 had subclinical hypothyroidism and one had hyperthyroidism. There was no statistically significant in gender and age between DS and control groups, however, TSH anomaly was significantly higher in the DS group (p = 0.008). Regarding thyroid autoantibodies, anti-TPO was positive in 13 cases (26%) and anti-TSH receptor was positive in 2 cases (4%). Statistically, there was no significant difference in TSH anomaly (p = 0.7), positive anti-TPO antibody (p = 0.097) and positive anti-TSH receptor antibody (p = 1.0) between males and females. The increased TSH levels had no statistically positive correlation with anti-TPO (p = 0.386) or anti-TSH receptor antibody (p=1) in this study. The prevalence of thyroid dysfunction was 18% (9/50) in DS patients in Taiwan. Most of them showed subclinical compensated hypothyroidism (16%, 8/50), and one (2%, 1/50) showed hyperthyroidism.
CONCLUSIONS: Thyroid dysfunction is common in DS patients, so periodic thyroid function tests should be performed and early treatment should be given to prevent further intellectual deterioration and improve overall development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18265539

Source DB:  PubMed          Journal:  Acta Paediatr Taiwan        ISSN: 1608-8115


  3 in total

1.  JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome.

Authors:  Kathryn D Tuttle; Katherine A Waugh; Paula Araya; Ross Minter; David J Orlicky; Michael Ludwig; Zdenek Andrysik; Matthew A Burchill; Beth A J Tamburini; Colin Sempeck; Keith Smith; Ross Granrath; Dayna Tracy; Jessica Baxter; Joaquin M Espinosa; Kelly D Sullivan
Journal:  Cell Rep       Date:  2020-11-17       Impact factor: 9.423

2.  Experience with Clinically Diagnosed Down Syndrome Children Admitted with Diarrhea in an Urban Hospital in Bangladesh.

Authors:  Rina Das; Anupam Sarker; Haimanti Saha; Abu Sadat Mohammad Sayeem Bin Shahid; K M Shahunja; Mohammod Jobayer Chisti
Journal:  Int Sch Res Notices       Date:  2015-05-07

3.  Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors.

Authors:  Rani K Powers; Rachel Culp-Hill; Michael P Ludwig; Keith P Smith; Katherine A Waugh; Ross Minter; Kathryn D Tuttle; Hannah C Lewis; Angela L Rachubinski; Ross E Granrath; María Carmona-Iragui; Rebecca B Wilkerson; Darcy E Kahn; Molishree Joshi; Alberto Lleó; Rafael Blesa; Juan Fortea; Angelo D'Alessandro; James C Costello; Kelly D Sullivan; Joaquin M Espinosa
Journal:  Nat Commun       Date:  2019-10-18       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.